Related Experiment Video
Updated: Aug 12, 2026

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
Opportunistic thoracic infections. Bacteria, viruses, and protozoa
1Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Abstract:
The range of potential bacterial, viral, and protozoan pathogens that can cause pulmonary infections in immunocompromised patients is extensive. An aggressive diagnostic approach is essential to maximizing chances for a successful outcome. This article discusses the general diagnostic approach and provides a discussion of the most important bacterial, viral, and protozoan chest infections occurring in this setting.
Insights
Immunocompromised patients face numerous bacterial, viral, and protozoan lung infections. An aggressive diagnostic strategy is crucial for successful treatment outcomes in these vulnerable individuals.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Immunocompromised patients are susceptible to a wide spectrum of pulmonary pathogens.
- Pulmonary infections in this population can lead to severe morbidity and mortality.
- Early and accurate diagnosis is critical for effective management.
Purpose of the Study:
- To outline a general diagnostic approach for pulmonary infections in immunocompromised patients.
- To review the most significant bacterial, viral, and protozoan chest infections in this demographic.
- To emphasize the importance of an aggressive diagnostic strategy.
Main Methods:
- Literature review of diagnostic strategies for pulmonary infections.
- Discussion of common and critical pathogens affecting immunocompromised hosts.
- Synthesis of current recommendations for clinical and laboratory diagnosis.
Main Results:
- The differential diagnosis for pulmonary infections in immunocompromised patients is broad.
- Specific bacterial, viral, and protozoan agents pose significant threats.
- Timely and comprehensive diagnostics improve patient prognoses.
Conclusions:
- An aggressive, systematic diagnostic approach is paramount for managing pulmonary infections in immunocompromised patients.
- Understanding the spectrum of potential pathogens guides diagnostic efforts.
- Successful outcomes depend on prompt identification and targeted therapy.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microbiota of the Respiratory Tract
Atypical Pneumonia
Pneumonia I: Introduction

